These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 20729877)

  • 1. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
    Im DS
    Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards selective lysophospholipid GPCR modulators.
    Archbold JK; Martin JL; Sweet MJ
    Trends Pharmacol Sci; 2014 May; 35(5):219-26. PubMed ID: 24746475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
    Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
    Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
    Goetzl EJ; Kong Y; Mei B
    J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subfamily of G protein-coupled cellular receptors for lysophospholipids and lysosphingolipids.
    Goetzl EJ; An S
    Adv Exp Med Biol; 1999; 469():259-64. PubMed ID: 10667339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.
    Dolezalova H; Shankar G; Huang MC; Bikle DD; Goetzl EJ
    J Cell Biochem; 2003 Mar; 88(4):732-43. PubMed ID: 12577307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases.
    Chun J; Rosen H
    Curr Pharm Des; 2006; 12(2):161-71. PubMed ID: 16454733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.
    Chun J; Hla T; Lynch KR; Spiegel S; Moolenaar WH
    Pharmacol Rev; 2010 Dec; 62(4):579-87. PubMed ID: 21079037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.
    Meyer zu Heringdorf D; Jakobs KH
    Biochim Biophys Acta; 2007 Apr; 1768(4):923-40. PubMed ID: 17078925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
    Takuwa Y; Takuwa N; Sugimoto N
    J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate.
    Goetzl EJ; An S
    FASEB J; 1998 Dec; 12(15):1589-98. PubMed ID: 9837849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate.
    Liu S; Paknejad N; Zhu L; Kihara Y; Ray M; Chun J; Liu W; Hite RK; Huang XY
    Nat Commun; 2022 Feb; 13(1):731. PubMed ID: 35136060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
    Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
    J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the pharmacological relevance of lysophospholipid receptors.
    Mutoh T; Rivera R; Chun J
    Br J Pharmacol; 2012 Feb; 165(4):829-44. PubMed ID: 21838759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.
    Kranenburg O; Moolenaar WH
    Oncogene; 2001 Mar; 20(13):1540-6. PubMed ID: 11313900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.
    Lee H; Goetzl EJ; An S
    Am J Physiol Cell Physiol; 2000 Mar; 278(3):C612-8. PubMed ID: 10712250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor.
    Goetzl EJ; Kong Y; Kenney JS
    Proc Assoc Am Physicians; 1999; 111(3):259-69. PubMed ID: 10354366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive lysophospholipids and their G protein-coupled receptors.
    Moolenaar WH
    Exp Cell Res; 1999 Nov; 253(1):230-8. PubMed ID: 10579925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies.
    Blaho VA; Chun J
    Trends Pharmacol Sci; 2018 Nov; 39(11):953-966. PubMed ID: 30343728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.